Which region will be controlling the global Artemisinin combination therapy market during 2023-2030?
The Middle East and Africa region holds and will be controlling the largest market share global artemisinin combination therapy market
Who are the key players contributing to the growth of Artemisinin combination therapy market?
Some of the key players which are contributing to the growth of the market include Novartis, Sanofi, Cipla, Ajanta Pharma, Ipca Laboratories, Guilin Pharmaceuticals
What is the Projected CAGR value of the Artemisinin combination therapy Market?
The global artemisinin combination therapy market is estimated to reach at a high CAGR during the forecast period (2023-2030).
What is Artemisinin combination therapy (ACT) used for?
Artemisinin combination therapy (ACT) is used for the treatment of plasmodium falciparum malaria.